Follow us on

wmedtour

Search
Close this search box.

Dr. NAIL SUAT UNVER

About Dr. NAIL SUAT UNVER

Internal Medicine , Nephrology

Education

  • 2015Istanbul Aydin University / Professor
  • 2007GATA Faculty of Medicine / Associate Professor
  • 2002Gulhane Military Medical Academy Nephrology
  • 1998Gulhane Military Medical Academy Internal Medicine
  • 1991Gulhane Military Medical Academy Faculty of Medicine

Experience

  • 2022Acıbadem Health Group
  • 2021 – 2022Liv Hospital Health Group
  • 2011 – 2021Central Hospital, Erdem Hospital, Medicana Health Group
  • 2011ÇAPA Faculty of Medicine, Department of Nephrology, Transplantation Unit
  • 2008 – 2011GATA Haydarpasa Training Hospital Nephrology Clinic (Associate Professor)
  • 2007 – 2008Kyrenia Military Hospital Chief Physician (Specialist)
  • 2002 – 2007GATA Haydarpaşa Training Hospital (Nephrology Specialist)
  • 2002Marmara University Department of Nephrology
  • 1998 – 2000Foça/İzmir (Internal Medicine Specialist)
  • 1992 – 1994Gölcük Garrison Infirmary Chief Physician (General Practitioner)
  • 1991 – 1992GATA Medical Faculty Hospital (Intern)

Memberships

  • Turkish Society of Nephrology Istanbul Branch
  • Turkish Organ Transplantation Organizations Coordination Association
  • European Association of Nephrology (ERA-EDTA)
  • Society for Transplantation Immunology and Genetics
  • Turkish Society of Nephrology

PUBLICATIONS

  • Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccineClinical Kidney Journal,2021 doi.10.1093/ckj/ sfab155 Unver S., Haholu A, Yildirim S.
  • Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.Ren Fail. 2015 Jun 1:1-6. Unver S, Kavlak E, Gümüsel HK, Celikbilek F, Esertas K, Müftüoglu T, Kirilmaz A.
  • Objective analysis of voice changes in a hemodialysis session and its correlation with ultrafiltration.For File. 2014 Dec 2:1-5. Unver S, Hardal U, Esertas K, Sezen A, Celikbilek F, Altundag A.
  • Cutaneous Kaposi”s sarcoma following immunosuppressive therapy for membranoproliferative glomerulonephritis.Clinical Nephrology 2009 72(5): 420-1 Atasoyu EM, Bilgi O, Kinalp J, Karagoz B, Haholu A, Unver S, Evrenkaya TR.
  • A Case of Peritonitis Resistant to Culture-Positive Treatment nephropathyClinical Nephrology 2009; 71(1): 100-102.
  • Oxidative stress potentials of different synthetic hemodialysis membranesDialysis & Transplantation 2008; 37(10): 397+. Unver S, Ipçioğlu OM, Kinalp C, Ozcan O, Atasoyu EM, Evrenkaya TR
  • A rare complication of idiopathic membranous nephropathy : crescentic transformation.Renal Failure 2008; 30(5): 573-575. Unver S, Haholu A, Atasoyu EM, Karatas M, Akcan R, Evrenkaya TR
  • The influence of the amount of ultrafiltration in chronic hemodialysis on P wave dispersion.Ren Fail. 2007;29(2):207-12 Unver S, Ozmen N, Aparci M, Atasoyu EM, Evrenkaya TR.
  • Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial mediterranean fever.Ren Fail. 2007 Jan;29 (1):73-77. Nadir H, Unver S, Ozel AM, Yazgan Y, Gultepe M, Evrenkaya TR, Demirturk L, Gurbuz AK.
  • What changes occur by only increasing blood flow rate in haemodialysis?International Review Of The Armed Forces Medical Services 2007. 80(3): 144-146. Unver S, Atasoyu EM, Evrenkaya TR, Tulbek MY